Introduction Modeling the dose-response profile of patients in drug and target studies is a very key component to these types of studies. In immunology, besides modeling patients' basophil expression level response to an agent, it also became necessary in other immunological assays and hence the need for
No takes yet. Share an insight, caveat, or question.
Usha Govindarajulu (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: